126 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
and Drug Administration.
“FDCA” means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §301 et seq.
“Federal Health Care Program” has the meaning … under any Federal Health Care Program; (ii) has been debarred, excluded or suspended from participation in any Federal Health Care Program; (iii) has had
D
ld628v480co35xaz93
14 Nov 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:51pm
8-K
EX-10.1
t6347
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
D
7fa1amnr
17 Oct 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:36pm
8-K
EX-10.1
4fdl0aaals
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
D
gb0f88t
15 Aug 22
$15M in equity / options / securities to be acquired, sold $15M, 6 investors
8:08pm
8-K
EX-10.1
pyoflsntcu 9n
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC 14D9
czpfz4is
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
ezb1i7m38k9lo
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
0af0cbky x4
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-10.2
33hcc
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
s4jw cbetxzu1
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
m055j
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K/A
EX-99.1
x1owr kp68h
16 Nov 21
Results of Operations and Financial Condition
6:30am